Today, medical imaging technologies such as X-ray and MRI machines are so ubiquitous across healthcare settings that it is difficult to imagine a life without them.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh